中国非小细胞肺癌放射治疗临床指南(2020版)  

Clinical practice guideline for radiation therapy of non-small cell lung cancer(2020 version)

作　　者：无 王绿化 于金明 傅小龙[8] 王平 陈明 卢冰 李宝生[12] 朱广迎[13] 无;Wang Lyuhua;Yu Jinming(Radiation Oncology Branch of Chinese Medical Association;Radiation Oncologist Branch of Chinese Medical Doctor Association Professional Committee on Radiation Oncology;China AntiCancer Association Experts Committee on Radiation Oncology;Radiation Oncologist Branch of Chinese Society of Clinical Oncology;Department of Radiation Oncology.National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital&Shenzhen Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Shenzhen 518116,China;Department of Radiation Oncology,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Ji'nan 250117,China)

机构地区：[1]中华医学会放射肿瘤治疗学分会 [2]中国医师协会放射肿瘤治疗医师分会 [3]中国抗癌协会放射治疗专业委员会 [4]中国临床肿瘤学会肿瘤放疗专家委员会 [5]国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科,100021 [6]国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院深圳医院,518116 [7]山东省肿瘤防治研究院(山东省肿瘤医院)放疗科山东第一医科大学(山东省医学科学院),济南250117 [8]上海市胸科医院 [9]天津医科大学肿瘤医院 [10]中国科学院大学附属肿瘤医院/浙江省肿瘤医院 [11]贵州医科大学附属医院/贵州省肿瘤医院 [12]山东省肿瘤医院 [13]中日友好医院

出　　处：《中华放射肿瘤学杂志》2020年第8期599-607,共9页Chinese Journal of Radiation Oncology

摘　　要：随着先进技术的迅速发展,放射治疗已进入精确放疗时代,精确放疗显著提高了肿瘤控制效果、降低了不良反应,对非小细胞肺癌(NSCLC)不同期别均发挥着重要作用。近年来,靶向治疗、免疫治疗等新疗法取得了突破性进展,为患者带来了生存获益。中华医学会放射肿瘤治疗学分会、中国医师协会放射肿瘤治疗医师分会、中国抗癌协会放射治疗专业委员会和中国临床肿瘤学会肿瘤放疗专家委员会联合组织相关专家,在NSCLC现有医学证据基础上,结合专家意见制订了《中国非小细胞肺癌放射治疗临床指南(2020版)》,内容主要包括概述、诊断、早中晚期治疗原则、放疗技术和随访等,以期为中国临床医生和患者提供针对放疗的NSCLC循证医学指南,指导临床实践。With the rapid development of advanced technology,it has entered the era of precise radiotherapy,which significantly improves tumor control and reduces treatment-related toxicities.Currently,radiotherapy plays a critical role in different stages of non-small cell lung cancer(NSCLC).Additionaly,targeted therapy,immunotherapy,and other new drug therapies have made breakthrough progress,bringing survival benefits to patients with NSCLC in recent years.Based on the existing medical evidence of NSCLC in combination with the expert opinions,clinical practice guidelines for radiation therapy of non-small cell lung cancer in China(2020)has been formulated by Chinese Society for Radiation Oncology,Radiation Oncologist Branch of Chinese Medical Doctor Association Professional Committee on Radiation Oncology,China Anti-Cancer Association and Experts Committee on Radiation Oncology,Chinese Society of Clinical Oncology.The main contents include overview,diagnosis,treatment principles for early-,middle-and advanced-stage NSCLC,radiotherapy and follow-up,etc.The purpose of this paper is to provide NSCLC evidence-based medical guidance for clinicians and patients in China and guide clinical practice.

关 键 词：癌 非小细胞肺/放射疗法 临床指南 

分 类 号：R734.2[医药卫生—肿瘤]